[Vaccination schedule of the Spanish association of paediatrics: recommendations 2010]

J Marès Bermúdez1, D van Esso Arbolave, J Arístegui Fernández

  • 1Comité Asesor de Vacunas de la Asociación Española de Pediatría, Madrid, España.

Insights

The Spanish Association of Paediatrics recommends updated childhood immunizations, prioritizing pneumococcal, rotavirus, and varicella vaccines. They also advise HPV vaccination for girls and influenza/hepatitis A for at-risk individuals.

Area of Science:

  • Pediatric Vaccinology
  • Public Health Policy
  • Epidemiology

Context:

  • The Vaccine Advisory Committee of the Spanish Association of Paediatrics annually updates immunization schedules.
  • Recommendations are based on epidemiological data, vaccine effectiveness, and efficiency.
  • A tiered system categorizes vaccines: universal, recommended, and for risk groups.

Purpose:

  • To provide an updated, evidence-based immunization schedule for children in Spain.
  • To prioritize key vaccinations based on public health impact and resource allocation.
  • To promote a unified national immunization schedule.

Summary:

  • The committee reaffirms routine pneumococcal vaccination.
  • Recommends rotavirus vaccination for all infants due to disease burden.
  • Advocates for varicella vaccination in the second year of life.
  • Supports HPV vaccination for girls aged 11-14, aligning with national guidelines.
  • Emphasizes influenza and hepatitis A vaccination for high-risk patients.
  • Stresses the importance of updating incomplete immunization records using accelerated schedules.

Impact:

  • Aims to improve child health outcomes through comprehensive vaccination coverage.
  • Contributes to reducing the incidence of vaccine-preventable diseases.
  • Provides a clear guideline for healthcare providers and public health officials.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.